We use cookies

Moalem Weitemeyer uses cookies, including cookies from third parties, needed to make the website work and to enhance the user experience. Cookies are also used to detect inexpediencies and to examine your interactions with our website. Read more about how we use cookies and take care of your data here

Necessary/functional

Statistical

Accept

18 September 2024

Moalem Weitemeyer advises Scandinavian Biolabs

Scandinavian Biolabs closes a series A round of EUR 4 million led by Aurea.

Scandinavian Biolabs is a Danish company specialising in science-backed, non-invasive, preventative products targeting early-stage hair loss. 

Aurea is a venture capital firm operating in London, New York and Paris. Aurea is the leading investment platform for New Age beauty, Wellness and Longevity.

This investment marks a significant milestone in Scandinavian Biolabs’ growth journey, further reinforcing their commitment to create innovative solutions for science-backed haircare. 

Moalem Weitemeyer advised Scandinavian Biolabs and its founders on all legal aspects of the transaction.

Jakob Skafte-Pedersen

Partner

+45 30 37 96 20

Go to profile

Tobias Riis Steinø

Partner

+45 30 37 96 97

Go to profile

Kadir Kurt

Associate

+45 30 37 96 27

Go to profile